Knockdown of PTK6 expression by shRNA or siRNA in tumor cells leads to significant inhibition of tumor growth, induction of tumor cell apoptosis, and suppression of metastases of triple negative breast cancer, while overexpression of PTK6 promotes cell proliferation [14–18]. This evidence concerns the gene PTK6 and triple-negative breast carcinoma.